Valeur pronostique du remodelage de la signalisation calcique dans le cancer de la prostate

Valeur pronostique du remodelage de la signalisation calcique dans le cancer de la prostate

Le cancer de prostate (CaP) est le plus fréquent chez l’homme de plus de 50 ans. La généralisation du PSA et du dépistage du CaP a permis son diagnostic à des formes localisées (80% des formes diagnostiquées), accessibles à un traitement curatif. De plus, un certain nombre de ces formes localisées s...

Full description

Bibliographic Details
Main Author:	Perrouin-Verbe, Marie-Aimée
Other Authors:	Brest
Language:	fr
Published:	2017
Subjects:	Cancer de prostate Marqueurs pronostiques Récidive Surveillance active Signalisation calcique Prostate cancer Prognostic markers Recurrence Active surveillance Calcium signalling 616.994 63
Online Access:	http://www.theses.fr/2017BRES0159

Similar Items

Etude de la signalisation calcique du lymphocyte B en pathologie
by: Fali, Tinhinane
Published: (2013)

UGT2B17 : marqueur de récidive biochimique du cancer de la prostate après prostatectomie radicale
by: Melo Garcia, Luciana
Published: (2019)

Ανοσοϊστοχημική μελέτη των υποδοχέων ανδρογόνων, οιστρογόνων, προγεστερόνης και ρετινοϊκού οξέος-α στην καλοήθη υπερπλασία και το αδενοκαρκίνωμα του προστάτη
by: Γυφτόπουλος, Κωνσταντίνος
Published: (2010)

MURC est un partenaire d’interaction de STIM1 impliqué dans la signalisation calcique
by: Frappier, Maude
Published: (2015)

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
by: Darian Andreas, et al.
Published: (2016-07-01)

Perineural invasion in prostate needle biopsy: Prognostic value on radical prostatectomy and active surveillance
by: Nuno Ramos, et al.
Published: (2020-12-01)

Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results
by: Ravi Kacker, et al.
Published: (2016-01-01)

Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
by: Salonee Shah, et al.
Published: (2021-05-01)

Μελέτη της δράσης συζευγμάτων πολυαμινών-όξινων ρετινοειδών σε καρκινικά κύτταρα προστάτη
by: Γιάννου, Αναστάσιος
Published: (2013)

Rates of primary and secondary treatments for patients on active surveillance for localized prostate cancer—A population‐based cohort study
by: Rano Matta, et al.
Published: (2020-10-01)

Two Decades of Active Surveillance for Prostate Cancer in a Single-Center Cohort: Favorable Outcomes after Transurethral Resection of the Prostate
by: Hagmann, S., et al.
Published: (2022)

Μορφολογική μελέτη της έκφρασης του PPARγ σε αδενοκαρκίνωμα του προστάτη
by: Κοψιδά, Γεωργία
Published: (2007)

Evaluation of various active surveillance protocols in prostate cancer
by: Kayhan Yılmaz, et al.
Published: (2014-06-01)

MRI and Active Surveillance for Prostate Cancer
by: Angelo Porreca, et al.
Published: (2020-08-01)

Changes in risk-group stratification of patients undergoing radical prostatectomy at the Southern Alberta Institute of Urology over time
by: Shiff B, et al.
Published: (2019-03-01)

Management and outcomes of Gleason six prostate cancer detected on needle biopsy: A single-surgeon experience over 6 years
by: Brayden March, et al.
Published: (2017-12-01)

Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)
by: Matteo Ferro, et al.
Published: (2017-05-01)

Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance
by: Roberta Mazzucchelli, et al.
Published: (2014-12-01)

Μελέτη του ρόλου του σηματοδοτικού μονοπατιού του mTOR σε σχέση με τη λεμφαγγειογένεση στο αδενοκαρκίνωμα του προστάτη
by: Λιλής, Ιωάννης
Published: (2015)

Etude de la régulation hormonale du métabolisme des alcaloïdes indoliques monoterpéniques chez Catharanthus roseus. Implication du calcium dans la transduction du signal induit par l'acide 2, 4- dichlorophénoxacétique
by: Poutrain, Pierre
Published: (2008)

Watchful Waiting Active Surveillance in Prostate Cancer Patients – a Population-Based Study Using the SEER-Medicare Linked Database
by: Kou, Tzuyung Doug
Published: (2008)

Computer Extracted Features from Initial H&E Tissue Biopsies Predict Disease Progression for Prostate Cancer Patients on Active Surveillance
by: Sacheth Chandramouli, et al.
Published: (2020-09-01)

Prostate volume effect on Gleason score upgrading in active surveillance appropriate patients
by: Emre Çamur, et al.
Published: (2019-07-01)

Current Progress and Controversies in Prostate Cancer Management
by: De-Xin Dong, et al.
Published: (2017-01-01)

Promise and Implementation of Proteomic Prostate Cancer Biomarkers
by: Agnieszka Latosinska, et al.
Published: (2018-08-01)

Psychosocial Correlates of Psychological Distress and Arousal in Prostate Cancer Survivors Undergoing Active Surveillance
by: Bustillo, Natalie Escobio
Published: (2011)

Analysis of different tumor volume thresholds of insignificant prostate cancer and their implications for active surveillance patient selection and monitoring
by: Dong Hoon Lee
Published: (2014-06-01)

Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables
by: Paolo Gandellini, et al.
Published: (2021-05-01)

Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study
by: Arnas Rakauskas, et al.
Published: (2021-07-01)

Un rôle inédit de la sortiline dans le contrôle du transport rétrograde de l'EGFR pour limiter la croissance tumorale
by: Al-Akhrass, Hussein
Published: (2017)

Considération de la dosimétrie Monte-Carlo et de l'oedème dans la planification inverse en curiethérapie prostate
by: Mountris, Konstantinos
Published: (2017)

Modern Approach in Radiological Diagnosis of Prostate Cancer (Systematic Review of International Clinical Guidelines and Clinical Studies Over 2014–2020)
by: A. V. Vasilyev, et al.
Published: (2021-01-01)

Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer Patients
by: Jinan Guo, et al.
Published: (2021-09-01)

A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance
by: Samuel W. D. Merriel, et al.
Published: (2021-02-01)

Radiobiological models based evaluation of the consequences of potential systematic catheter shifts in the HDR brachytherapy of prostate cancer
by: Kefala, Vasiliki
Published: (2010)

Μοριακοί δείκτες στη σταδιοποίηση της λεμφαδενικής νόσου στον καρκίνο του προστάτη
by: Τορονίδης, Χαράλαμπος
Published: (2010)

Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer?
by: Subhabrata Mukherjee, et al.
Published: (2021-02-01)

Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy
by: Pietro Pepe, et al.
Published: (2016-12-01)

The role of mpMRI in qualification of patients with ISUP 1 prostate cancer on biopsy to radical prostatectomy
by: Łukasz Nyk, et al.
Published: (2021-05-01)

THE LONG-TERM ONCOLOGICAL RESULTS OF RADICAL PROSTATECTOMY IN PATIENTS WITH A MAXIMUM FOLLOW-UP OF UP TO 15 YEARS, WHO MEET THE ERSPC (PRIAS) CRITERIA FOR ACTIVE SURVEILLANCE
by: E. I. Veliev, et al.
Published: (2014-07-01)